Brain natriuretic peptide as a potential marker of acute coronary syndromes

Emergency Medicine Journal

Volumn 23, Issue 5, 2006, Pages 403-407

  Carley, Simon D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TROPONIN I; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; COCHRANE LIBRARY; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE MARKER; EMBASE; EVIDENCE BASED MEDICINE; FALSE POSITIVE RESULT; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE NECROSIS; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; MEDLINE; MORTALITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; ACUTE DISEASE; BLOOD; CORONARY ARTERY DISEASE; REVIEW; SYNDROME;

ACUTE DISEASE; BIOLOGICAL MARKERS; CORONARY DISEASE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; SYNDROME;

EID: 33744986700     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2006.036608     Document Type: Short Survey

References (16)

1. Hall C. Essential biochemistry and physiology of (NT-pro) BNP. European Journal of Heart Failure 2004;6:257-260.
2. Omland T, Aakvaag A, Bonarjee WS, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation 1996;93:1963-1969.
3. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clinical Science 1995;88:551-556.
4. Motwani JG, McAlpine H, Kennedy N, et al. Plasma brain natriuretic peptide as an indicator for angiotensin-converting enzyme inhibition after myocardial infarction. Lancet 1993;341(8853):1109-1113.
5. Ruck A, Gustaffson T, Norrborn J, et al. ANP and BNP but not VEGF are regionally overexpressed in ischemic human myocardium. Biochemical and Biophysical Research Communications 2004;322:287-291.
6. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New England Journal of Medicine 2002;347:161-167.
7. Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. Journal of the American College of Cardiology 2002;39(2):202-209.
8. Goetze JP, Gore A, Moller CH, et al. Acute myocardial hypoxia increases BNP gene expression. FASEB Journal 2004;18(15):1928-1930.
9. Mukoyama M, Nakao K, Obata K, et al. Augmented secretion of brian natriuretic peptide in acute myocardial infarction. Biochemical and Biophysical Research Communications 1991;180(1):431-436.
10. Horio T, Shimada KE, Hokno M, et al. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. American Heart Journal 1993;126:293-299.
11. Morita E, Hirofumi Y, Michihiro Y, et al. Myocardial injury/infarction: increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1991;88(1):82-91.
12. Kikuta K, Yasue H, Yoshimura M, et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. American Heart Journal 1996;132:101-107.
13. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. New England Journal of Medicine 2001;345:1014-1021.
14. Morrow DA, de Lemos JA, Sbatine MS, et al. Evaluation fo B-type natriuretic peptide for risk assessment in unstable angina/ non-ST-elevation myocardial infarction. B-type natriuretic peptide and prognosis in TACTICS-TIMI. Journal of the American College of Cardiology 2003;41(8):1264-1272.
15. Mega JL, Morrow DA, de Lemos JA, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction. An ENTIRE-TIMI-23 substudy. Journal of the American College of Cardiology 2004;44(2):335-339.
16. Bassan R, Potsch A, Maisel A, et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. European Heart Journal 2005;26:234-240.